EA200702039A1 - 7-NATIONAL CONSUMPTIONAL CONSULTANCY HOUSEHOLD MEMBERSHIP - Google Patents

7-NATIONAL CONSUMPTIONAL CONSULTANCY HOUSEHOLD MEMBERSHIP

Info

Publication number
EA200702039A1
EA200702039A1 EA200702039A EA200702039A EA200702039A1 EA 200702039 A1 EA200702039 A1 EA 200702039A1 EA 200702039 A EA200702039 A EA 200702039A EA 200702039 A EA200702039 A EA 200702039A EA 200702039 A1 EA200702039 A1 EA 200702039A1
Authority
EA
Eurasian Patent Office
Prior art keywords
consumptional
consultancy
national
household membership
membership
Prior art date
Application number
EA200702039A
Other languages
Russian (ru)
Other versions
EA014554B1 (en
Inventor
Юджин Б. Грант III.
Марк Дж. Мэсилаг
Стивен Дэвид Пэджет
Мишель Энн Вейднер-Уэллс
Сяоцин Сюй
Сяодун Сюй
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200702039A1 publication Critical patent/EA200702039A1/en
Publication of EA014554B1 publication Critical patent/EA014554B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Настоящее изобретение относится к соединениям, имеющим структуру, представленную формулой (I), где n, m, z, R, R, R, R, R, R, A, E, X, Y, а и b такие, как определены в формуле изобретения; или их оптическому изомеру, диастереомеру или энантиомеру; их фармацевтически приемлемой соли, гидрату или пролекарству.The present invention relates to compounds having the structure represented by formula (I), where n, m, z, R, R, R, R, R, R, A, E, X, Y, a and b are as defined in the claims; or their optical isomer, diastereomer or enantiomer; their pharmaceutically acceptable salt, hydrate or prodrug.

EA200702039A 2005-03-21 2006-02-02 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones EA014554B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/084,987 US7732612B2 (en) 2004-09-09 2005-03-21 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
PCT/US2006/003657 WO2006101603A1 (en) 2005-03-21 2006-02-02 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Publications (2)

Publication Number Publication Date
EA200702039A1 true EA200702039A1 (en) 2008-02-28
EA014554B1 EA014554B1 (en) 2010-12-30

Family

ID=36648281

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702039A EA014554B1 (en) 2005-03-21 2006-02-02 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Country Status (22)

Country Link
US (1) US7732612B2 (en)
EP (1) EP1861401B1 (en)
JP (1) JP4977684B2 (en)
KR (1) KR101323665B1 (en)
CN (1) CN101248070B (en)
AR (1) AR053342A1 (en)
AU (1) AU2006227984A1 (en)
BR (1) BRPI0609426B8 (en)
CA (1) CA2602140C (en)
CR (1) CR9458A (en)
DK (1) DK1861401T3 (en)
EA (1) EA014554B1 (en)
ES (1) ES2561834T3 (en)
IL (1) IL186041A (en)
MX (1) MX2007011774A (en)
MY (1) MY147638A (en)
NO (1) NO340833B1 (en)
NZ (1) NZ561651A (en)
TW (1) TWI444380B (en)
UA (1) UA93672C2 (en)
WO (1) WO2006101603A1 (en)
ZA (1) ZA200708868B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7913302B2 (en) * 2004-05-02 2011-03-22 Markmonitor, Inc. Advanced responses to online fraud
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
EA200801128A1 (en) * 2005-10-21 2008-10-30 Глэксо Груп Лимитед PERI-CONDENSED TRICYCLIC COMPOUNDS USEFUL AS ANTIBACTERIAL MEANS
EP1963324B1 (en) 2005-12-22 2010-04-21 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
ATE507219T1 (en) * 2006-03-28 2011-05-15 Warner Chilcott Co Llc MALATE SALTS AND POLYMORPHS OF (3S,5S)-7-Ä3-AMINO-5-METHYL-PIPERIDINYLÜ-1-CYCLOPROPYL-1,4-DIHYDRO 8-METHOXY-4-OXO-3-QUINOLINECARBONIC ACID
KR101084521B1 (en) 2006-03-28 2011-11-18 워너 칠콧 컴퍼니 엘엘씨 A coupling process for preparing quinolone intermediates
KR101245938B1 (en) 2008-05-29 2013-03-21 블루스타 실리콘즈 프랑스 에스에이에스 Article having antifouling properties for aquatic and particularly sea use
EA201490435A1 (en) 2011-08-10 2014-06-30 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД ANTIBACTERIAL 3,4-DIHYDRO-1N- [1,8] NAFTYRIDINOES FIXED BY PIPERIDINYL
JO3611B1 (en) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
CN105237464B (en) * 2011-09-30 2018-06-01 詹森药业有限公司 It is used to prepare the improved method of 2- [(2E) -2- fluoro- 2- (3- piperidylidenes) ethyl] -1H- iso-indoles -1,3 (2H)-diketone
US9388178B2 (en) * 2012-12-04 2016-07-12 Mankind Research Centre Process for the preparation of moxifloxacin hydrochloride
WO2016079757A2 (en) * 2014-11-19 2016-05-26 Symed Labs Limited Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK164287A (en) 1986-03-31 1987-10-01 Sankyo Co QUINOLIN-3-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF AND THEIR USE
JPH0262875A (en) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd Novel isoindoline derivative
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
FR2692577B1 (en) * 1992-05-26 1996-02-02 Bouchara Sa NOVEL FLUORINATED QUINOLONES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
NO304832B1 (en) * 1992-05-27 1999-02-22 Ube Industries Aminokinolone derivatives and anti-HIV agents
JPH07300472A (en) * 1992-12-28 1995-11-14 Korea Res Inst Chem Technol New quinolone carboxylic acid derivative and its preparation
JPH06263754A (en) 1993-03-12 1994-09-20 Hokuriku Seiyaku Co Ltd 7-aminopyrrolidinylquinoline-3-carboxylic acid
CZ299554B6 (en) 1997-09-15 2008-09-03 The Procter & Gamble Company Compound with quinolone structure, pharmaceutical composition containing thereof and use of such compound
US6878713B2 (en) * 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
BRPI0414573A (en) * 2003-09-22 2006-11-07 Janssen Pharmaceutica Nv 7-amino heterocyclic alkylidenyl quinolones and naphthyridones

Also Published As

Publication number Publication date
TWI444380B (en) 2014-07-11
EP1861401A1 (en) 2007-12-05
CN101248070B (en) 2011-12-14
CN101248070A (en) 2008-08-20
CA2602140A1 (en) 2006-09-28
UA93672C2 (en) 2011-03-10
AR053342A1 (en) 2007-05-02
BRPI0609426A2 (en) 2010-04-06
IL186041A (en) 2016-05-31
CA2602140C (en) 2015-04-14
US20060052359A1 (en) 2006-03-09
TW200700418A (en) 2007-01-01
KR20070113304A (en) 2007-11-28
ZA200708868B (en) 2009-01-28
JP4977684B2 (en) 2012-07-18
EP1861401B1 (en) 2015-11-18
CR9458A (en) 2008-09-09
BRPI0609426B8 (en) 2021-05-25
MX2007011774A (en) 2008-03-10
NZ561651A (en) 2011-09-30
US7732612B2 (en) 2010-06-08
ES2561834T3 (en) 2016-03-01
AU2006227984A1 (en) 2006-09-28
WO2006101603A1 (en) 2006-09-28
BRPI0609426B1 (en) 2020-09-24
MY147638A (en) 2012-12-31
EA014554B1 (en) 2010-12-30
JP2008538110A (en) 2008-10-09
DK1861401T3 (en) 2015-12-07
IL186041A0 (en) 2008-02-09
KR101323665B1 (en) 2013-10-31
NO20075385L (en) 2007-12-14
NO340833B1 (en) 2017-06-26

Similar Documents

Publication Publication Date Title
EA200702039A1 (en) 7-NATIONAL CONSUMPTIONAL CONSULTANCY HOUSEHOLD MEMBERSHIP
HRP20120323T1 (en) Diarylhydantoin compounds
RS54485B1 (en) C7-fluoro substituted tetracycline compounds
EA201000395A1 (en) 2-Alkylthio-2-
EA200800760A1 (en) PYRIDOPYRIMIDINONE INHIBITORS PI3Kα
EA201100875A1 (en) NEW PYRAZOL-4-N-ALKOXYCARBOXAMIDES AS MICROBIOCIDES
CY1112467T1 (en) 1-SULF-D-GLYCITOLIS PRODUCT
EA200801560A1 (en) BIFENYL CARBOKSAMIDES
EA201000950A1 (en) AZOLYLMETHYLOXYRANES, THEIR APPLICATION, AND ALSO CONTAINING THEM
EA201070597A1 (en) ANTIBACTERIAL ANALOGUES OF AMINOGLICOSIDE
ATE483000T1 (en) NAPHTALINE-AMIDINE-IMIDE
GEP20104943B (en) Fused heterocyclic compounds useful as kinase modulators
EA201000883A1 (en) INDOLINONA DERIVATIVES AND METHOD FOR THEIR PRODUCTION
EA201000396A1 (en) NEW FUNGICIDES
EA201100794A1 (en) SUBSTITUTED PYRIMIDINES INTENDED FOR THE TREATMENT OF DISEASES, SUCH AS CANCER
EA201000269A1 (en) NEW HERBICIDES
CY1105994T1 (en) ARRANGEMENT PENTANOLS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
GB0521508D0 (en) Organic compounds
EA200801199A1 (en) KINASE INHIBITORS
MY176860A (en) 7-amino alkylidenyl-heterocyclic quinolones and napthyridones
EA200801413A1 (en) HETEROCYCLIC CETR INHIBITORS
UA106880C2 (en) NEW HERBICIDES
EA201001348A1 (en) Pyrrolipyrimidinkarboxamides
EA200702290A1 (en) MOTYLIDE COMPOUNDS
EA200600760A1 (en) NEW COMPOUNDS PHENILPYRIDILPIPERAZINE, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM